All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
André Jefremow,1,2 Markus F Neurath1,2 1Department of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 2Deutsches Zentrum Immuntherapie (DZI), Erlangen, GermanyCorrespondence: André JefremowDepartment of Medicine 1, Friedrich-A...
Main Authors: | Jefremow A, Neurath MF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/all-are-equal-some-are-more-equal-targeting-il-12-and-23-in-ibd-ndash--peer-reviewed-article-ITT |
Similar Items
-
Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD
by: Heather Armstrong, et al.
Published: (2021-01-01) -
Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
by: Deepak P, et al.
Published: (2016-11-01) -
Next generation of biologics for the treatment of Crohn’s disease: an evidence-based review on ustekinumab
by: Jauregui-Amezaga A, et al.
Published: (2017-11-01) -
Editorial: Microbiome in IBD: From Composition to Therapy
by: Ruixin Zhu, et al.
Published: (2021-06-01) -
Current status of IBD and surgery of Crohn's disease in Thailand
by: Woramin Riansuwan, et al.
Published: (2021-09-01)